
Rachel Besser
@besserbesser
Paediatric endo, researcher @T1Early, 39y experience living with #T1D, writer of grants, plays & books: Diabetes Through the Looking Glass. Views my own.
ID: 526212635
16-03-2012 09:29:33
346 Tweet
631 Followers
593 Following



On May 18th the New Scientist Events will become a platform to hear all about #type1diabetes #screening and intervention, hope to see you there! The future of #medicine? The audience will decide....New Scientist Fulya Mehta Partha S Kar 🇮🇳🇬🇧🏏🎥 @clarehambling Richard Oram newscientist.com/science-events…


Talking all things type 1 diabetes with Rachel Besser (pinched your photo!), Alzheimer's with Jon Rohrer and the brain with Nick Davis at New Scientist Events Future of Medicine event


Huge congrats to Anastasia at Breakthrough T1D for masterminding this consensus, and Moshe and Linda for their leadership. Proud to co chair the paediatric working group. pubmed.ncbi.nlm.nih.gov/38912694/ #T1Diabetes # screening

How can you monitor a child, young person or adult with positive antibodies in clinical practice? Here's how ....pubmed.ncbi.nlm.nih.gov/38912694/ Rachel Besser #T1diabetes

A general population screening strategy for #T1D? Aligning with a vaccination visit looks feasible and acceptable in this proof of concept study T1Early National Institute for Health and Care Research NIHR Oxford Biomedical Research Centre @besser adc.bmj.com/content/early/…


#Screening for #T1D is nothing without its follow-up programme, but when is the right rime to start #insulin in an individual gradually evolving to stage 3 T1d? Here are some thoughts The Lancet Diabetes & Endocrinology Rachel Besser Fulya Mehta Parth thelancet.com/journals/landi…

Screening begins in Portugal as part of Eden Shochat

New data presented at #ISPAD50 from the BANDIT clinical trial show baricitinib can help people newly diagnosed with #Type1Diabetes keep making insulin better than placebo for up to 2 years. Learn more on Breakthrough T1D UK website: breakthrought1d.org.uk/news/world-fir… @JDRFaus


Moshe Phillip presents the T1D screening program Clalit Health Tel Aviv University #ispad2024 👉🏿prevention of DKA 👉🏿a chance for prevention of stage 3 T1D 🤞🏼 👉🏿a pathway to the population screening with a hope for the cure 🤘🏽 ISPAD Advanced Technologies & Treatments for Diabetes Julia Mader🇺🇦🇺🇦🇦🇹🏳️🌈🇪🇺🇮🇱🇺🇦🇺🇦 Emma Wilmot Rachel Besser


UKPDS keeps giving! The risk of mortality greater for young onset T2 diabetes relative to the general population Congratulation to Amanda I Adler et al sciencedirect.com/science/articl… The Lancet Diabetes & Endocrinology


Thank you Diabetes UK for a great conference, full of hope and excitement for the future of #T1D. Great to make new connections and renew those established Shivani Misra Partha S Kar 🇮🇳🇬🇧🏏🎥 Katharine Owen Emma Wilmot Fulya Mehta Faye Riley Elizabeth Robertson Rachel Ann Connor hilarynathan

Our BSPED survey is out! Children are picked up with Pre-stage 3 #T1D from clinical care & research with no consensus on f-up - we're on to it 💪👷♀️💪! Rabbi Swaby Partha S Kar 🇮🇳🇬🇧🏏🎥 Clare Hambling Fulya Mehta T1Early doi.org/10.1111/dme.70… pic.x.com/PaGVG4s1Sh


Watch this space! This could be the start of something amazing for #T1D #making plans together. Strength is working together rather than in silos BSPED PCDO Society Ketan Dhatariya T1Early


Now in Durham to join NE/ N Cumbria paed diabetes network to talk #T1D #screening & #implementation. Gr8 to hear views of Young Leaders, 88 years combined experience of T1D! Floating ideas discussed yesterday with ABCD Diabetes PCDO Society Ketan Dhatariya BSPED T1Early

